SoftBank Shares Fall After $10 Billion OpenAI Investment 
Sanofi, Regeneron Expand Drug Partnership in $8 Billion Deal 
XRP Ledger Hits 10 Million AI Payments as Bitcoin Retreats 
Trump Praises Boeing 737 Max After Flydubai Crash Attempt 
Airbus Spain Workers Approve Deal to End Months of Strikes 
Lynas Shares Slide on A$968 Million Meteoric Resources Deal 
Robinhood Stock Nears $114 as Jobs Data Boosts Risk Appetite 
AAVE, PUMP, WLD and SKY Rally as Crypto Market Slips 
Flydubai Co-Pilot Tried to Crash Israel-Bound Jet, Netanyahu Says 
Ripple Locks 700 Million XRP Back in Escrow After October Release 
Volvo Cars Drops Full-Year Outlook as China, US Sales Weaken 
WordPress Malware Uses Ethereum to Evade Removal 
Circle Urges EU to Revise MiCA Stablecoin Rules 
Bank of America Sees EUR/USD at 1.15 by Year-End 
MSTR Stock Rises 3% as Strategy Challenges MSCI Bitcoin Stance 
Goldman Sachs Names CATL, Zenergy Top China Battery Picks 
Add as a preferred source on Google
LOS ANGELES, June 12, 2017 -- Lundin Law PC , a shareholder rights law firm, announces a class action lawsuit against Lion Biotechnologies, Inc. (“Lion” or the “Company”) (Nasdaq:LBIO) for possible violations of federal securities laws between November 14, 2013 and April 10, 2017 inclusive (the “Class Period”). Investors who purchased or otherwise acquired shares during the Class Period should contact the firm by the June 13, 2017 lead plaintiff motion deadline.
To participate in this class action lawsuit, click here.
You can also call Brian Lundin, Esq., of Lundin Law PC, at 888-713-1033, or you can e-mail him at [email protected].
No class has been certified in the above action yet. Until a class is certified, you are not considered represented by an attorney. You may choose to do nothing and be an absent class member as well.
The Complaint alleges that throughout the Class Period, Lion made false and/or misleading statements and/or failed to disclose: that the Company, through its former Chief Executive Officer (“CEO”) Manish Singh, engaged in a scheme to mislead investors by commissioning over 10 internet publications and 20 widely distributed emails promoting Lion to potential investors that purported to be independent from the company when they were actually paid promotions; that former CEO Singh engaged a notorious stock promotion firm to pay writers to publish articles about the Company on investment websites and to coordinate the distribution of articles to thousands of electronic mailboxes; that former CEO Singh actively participated in the promotional work for Lion and understood that the promotion firm was using writers who would not disclose that Lion was indirectly compensating them for their publications; and that as a result of the above, Lion’s public statements were materially false and misleading at all relevant times. Following this news, Lion’s stock price dropped materially, which caused investors harm according to the Complaint.
Lundin Law PC was founded by Brian Lundin, a securities litigator based in Los Angeles dedicated to upholding shareholders’ rights.
This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and ethics rules.
Contact: Lundin Law PC Brian Lundin, Esq. Telephone: 888-713-1033 Facsimile: 888-713-1125 [email protected] http://lundinlawpc.com/
